Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
Ole Wichmann(Robert Koch Institute), Gabriele Peyerl‐Hoffmann(University of Freiburg), Joaquím Gascón(Instituto de Salud Carlos III), Nikolai Mühlberger(Robert Koch Institute), Heli Siikamäki(Helsinki University Hospital), Guido Calleri, Tomáš Jelı́nek(University Hospital Ostrava), Anders Sundøy(Sørlandet Sykehus), Blaise Genton(Ifakara Health Institute), Peter Kern(St. Elisabeth-Hospital Bochum), Mirjam Schunk(LMU Klinikum), Joannes Clerinx, Rogelio López‐Vélez(Instituto de Salud Carlos III), Sabino Puente(Instituto de Salud Carlos III), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Ida Gjørup(University of Copenhagen)
Cited by 173
Related Papers
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
|PLoS neglected tropical diseases|2017|990
Neurological complications of dengue virus infection
|The Lancet Neurology|2013|500
Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
|Nature Genetics|2001|480
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396